Ageing & Movement Research Group

AMRG logo

The Ageing and Movement Research Group is a dynamic, multidisciplinary research collaboration, focused on ageing and movement disorders.

The AMRG run a portfolio of studies in older adults with a focus on Parkinson's. This includes the £2.1 million CHIEF-PD trial that seeks to evaluate whether cognitive enhancement with rivastigmine prevents falls and the £10 million PRIME Parkinson programme that innovates care in Parkinson's. We also have an educational workstream that innovates teaching methods in geriatric medicine. 

Visit our website here for more information

 

Edit this page